277 filings
8-K
ReShape Lifesciences Inc.
15 Jun 21
Completion of Acquisition or Disposition of Assets
5:11pm
8-K
ReShape Lifesciences Inc.
19 May 21
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
ReShape Lifesciences Inc.
17 May 21
ReShape Lifesciencs Announces First Quarter 2021 Financial and Operational Results
4:16pm
8-K
ReShape Lifesciences Inc.
10 Mar 21
ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results
4:35pm
8-K
ReShape Lifesciences Inc.
20 Jan 21
Entry into a Material Definitive Agreement
8:47am
8-K
hdnys czcwys
22 Dec 20
Entry into a Material Definitive Agreement
10:21am
8-K
79yga ria7lboslendm8
12 Nov 20
ReShape Lifesciences Announces Third Quarter 2020 Financial and Operational Results
4:45pm
8-K
mcuad29pomfwj
15 Sep 20
Entry into a Material Definitive Agreement
9:00am
8-K
8rtdeav55b9egurm7vy1
13 Aug 20
ReShape Lifesciences Announces Second Quarter 2020 Financial and Operational Results
4:30pm
8-K
mzz2rdew tsqn5u3w
26 Jun 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:07pm
8-K
eb5uhn4d2 a38dj5ip7
14 May 20
ReShape Lifesciences Announces First Quarter 2020 Financial Results
4:28pm
8-K
fzd9urno1
31 Mar 20
Entry into a Material Definitive Agreement
5:21pm
8-K
d01cn7 5v8de9auoeeq
31 Mar 20
Other Events
4:48pm
8-K
vczop45i
26 Mar 20
ReShape Lifesciences Announces Fourth Quarter and Full Year 2019 Financial Results
5:24pm
8-K
bes973
5 Mar 20
Departure of Directors or Certain Officers
4:30pm
8-K
d2lhrd97u76ty3e9oep
14 Nov 19
ReShape Lifesciences Announces Third Quarter 2019 Financial Results
4:05pm
8-K
f9fhff62bvlug4t
6 Nov 19
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
r6hw5xgiq
30 Oct 19
ReShape Lifesciences Appoints Thomas Stankovich as Chief Financial Officer
4:06pm
8-K
y0r3yt07shf
24 Oct 19
Termination of a Material Definitive Agreement
4:11pm
8-K
37apfrxfjyrm1
30 Sep 19
Entry into a Material Definitive Agreement
6:07am